Stockscreener 앱 받기
6.37
0.16%
-0.010
전일 마감가:
$6.38
열려 있는:
$6.38
하루 거래량:
243.78K
Relative Volume:
0.52
시가총액:
$320.99M
수익:
$230.47M
순이익/손실:
$30.28M
주가수익비율:
10.44
EPS:
0.61
순현금흐름:
$38.86M
1주 성능:
+4.26%
1개월 성능:
+12.35%
6개월 성능:
+85.17%
1년 성능:
+110.93%
1일 변동 폭
$6.34
$6.4768
1주일 범위
$6.05
$6.4768
52주 변동 폭
$2.575
$6.4768
Puma Biotechnology Inc Stock (PBYI) Company Profile
명칭
Puma Biotechnology Inc
전화
(424) 248-6500
주소
10880 WILSHIRE BLVD., LOS ANGELES, CA
PBYI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
6.37 | 321.50M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-28 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Underperform |
| 2019-10-08 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-05-10 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-01-17 | 개시 | Leerink Partners | Mkt Perform |
| 2019-01-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2018-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-11-02 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-17 | 개시 | Goldman | Sell |
| 2018-05-11 | 재확인 | Stifel | Buy |
| 2017-11-10 | 재확인 | Citigroup | Buy |
| 2017-11-10 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | 재확인 | Stifel | Buy |
| 2017-09-11 | 재확인 | Credit Suisse | Outperform |
| 2017-07-10 | 재개 | Leerink Partners | Outperform |
| 2017-06-06 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | 재확인 | RBC Capital Mkts | Sector Perform |
모두보기
Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스
Puma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
EPS Watch: How Puma Biotechnology Inc stock valuations compare to rivalsWeekly Stock Analysis & High Accuracy Trade Signal Alerts - Bộ Nội Vụ
Death Cross: Can Puma Biotechnology Inc stock beat analyst upgradesJuly 2025 Big Picture & High Accuracy Investment Signals - Bộ Nội Vụ
Investing in Puma Biotechnology (NASDAQ:PBYI) a year ago would have delivered you a 103% gain - Yahoo Finance
Investor Mood: What dividend safety score for Puma Biotechnology Inc. stock2025 Market Outlook & Weekly Watchlist of Top Performers - Bộ Nội Vụ
Will Puma Biotechnology Inc. stock keep outperforming rivalsTrade Risk Report & AI Enhanced Execution Alerts - Улправда
Puma Biotechnology (NASDAQ:PBYI) CEO Sells $105,910.56 in Stock - MarketBeat
Puma Biotechnology (NASDAQ:PBYI) Insider Douglas Hunt Sells 3,973 Shares - MarketBeat
Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI By Investing.com - Investing.com Nigeria
Puma biotech CFO Nougues sells $64k in shares By Investing.com - Investing.com Australia
Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k By Investing.com - Investing.com Australia
Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI - Investing.com
Puma biotech CFO Nougues sells $64k in shares - Investing.com
Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k - Investing.com
Will Puma Biotechnology Inc. stock continue dividend increasesEarnings Trend Report & Reliable Price Breakout Signals - Улправда
Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Puma Biotechnology reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Puma Biotechnology Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? - Yahoo Finance
Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - sharewise.com
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - BioSpace
Puma Biotechnology Added to Nasdaq Biotechnology Index - marketscreener.com
If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity - Yahoo Finance
How Puma Biotechnology Inc. stock reacts to oil pricesPortfolio Value Report & Low Risk High Reward Trade Ideas - Улправда
What dividend safety score for Puma Biotechnology Inc. stockJuly 2025 Momentum & Long-Term Growth Portfolio Plans - Улправда
What analyst consensus says on Puma Biotechnology Inc. stock2025 Buyback Activity & Expert Curated Trade Setups - Улправда
History Review: How Puma Biotechnology Inc. stock reacts to oil pricesWeekly Risk Report & AI Driven Stock Reports - Улправда
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - TradingView — Track All Markets
Why analysts upgrade Puma Biotechnology Inc stock2025 Winners & Losers & Consistent Income Trade Ideas - moha.gov.vn
Puma Biotechnology Earnings Notes - Trefis
Acorn Capital Advisors LLC Has $14.17 Million Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case - Sahm
American Century Companies Inc. Grows Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat
What analysts say about Puma Biotechnology Inc stockStock Liquidity Analysis & Minimal Investment Capital Gains - earlytimes.in
Can Puma Biotechnology Stock Hold Up When Markets Turn? - Trefis
What insider trading reveals about Puma Biotechnology Inc. stock2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Los Angeles Daily NewsPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners - Yahoo Finance
Puma Biotechnology, Inc. (PBYI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Puma Biotechnology Inc (PBYI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Puma Biotechnology Inc 주식 (PBYI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| AUERBACH ALAN H | President and CEO |
Jan 06 '26 |
Sale |
5.84 |
16,938 |
98,986 |
7,163,963 |
| HUNT DOUGLAS M | See Remarks |
Jan 07 '26 |
Sale |
5.88 |
5,014 |
29,477 |
155,907 |
| HUNT DOUGLAS M | See Remarks |
Jan 06 '26 |
Sale |
5.84 |
3,973 |
23,218 |
160,921 |
| NOUGUES MAXIMO F | Chief Financial Officer |
Jan 07 '26 |
Sale |
5.88 |
6,405 |
37,655 |
193,284 |
| NOUGUES MAXIMO F | Chief Financial Officer |
Jan 06 '26 |
Sale |
5.84 |
4,540 |
26,532 |
199,689 |
4.73%
0.92%
자본화:
|
볼륨(24시간):